DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/5c8442/brazil_generics_ma) has announced the addition of the "Brazil Generics Market Forecast to 2012" report to their offering.
Since the initial launch of policies, Brazil generic drugs market has been experiencing a stupendous growth. The country is the largest generics market in Latin America and is poised to become one of the fastest growing regions in coming years. This marvelous performance of the sector is accredited to various factors such as, patent expirations, liberal government policies, aging population, high investments etc. The Brazilian generics market is expected to witness a significant rise in revenue and consumption in future as good quality products, untapped space for growth, and the government support will back the industry. It is expected that the generics market will post a CAGR of nearly 19% during 2010 - 2012.
According to this latest report entitled Brazil Generics Market Forecast to 2012, various segments of the Brazilian generic drugs sector has supported the overall market growth. Segments such as, diabetes, antithrombotics, erectile dysfunction, oral contraceptive, antiretroviral, and cardiovascular are the key growth areas of the industry. Of these, diabetes, antiretroviral, cardiovascular, and oral contraceptive holds a significant potential for future growth.
This research report has found that there are various market trends that may impact the industry developments in near future. Growing presence of multinational players, rising registration of generics, and focus on generic active ingredients are some of the important trends. Emphasis on generic active ingredients is rising as the patents of older branded substances are about to expire and manufacturers are beginning to launch new versions. This trend holds prominent significance as it may further boost the generics and bring in investments.
The report provides a complete overview and rational analysis of the Brazilian generics market. It has covered key aspects of the industry and thoroughly examined market performance in recent years. A prudent analytical review of market drivers, disease profile, regulatory scenario, and industry restraints has also been provided that will help clients understand the key factors associated with the industry. Moreover, the competitive landscape section elaborates upon the recent developments of key players and their strengths and weaknesses.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Market Overview
4. Market Drivers
5. Industry Performance 6. Market Trends
7. Regulatory Environment
8. Industry Restraints & RNCOS Recommendation 9. Key Players Companies Mentioned:
- EMS Sigma Pharma
- Medley
- Eurofarma Laboratories Ltd
- Ach Pharmaceutical Laboratories S/A
- Ranbaxy
For more information visit http://www.researchandmarkets.com/research/5c8442/brazil_generics_ma
CONTACT:
Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
KEYWORDS: Brazil South America
INDUSTRY KEYWORDS: Health Pharmaceutical
MEDIA:
| Logo |